FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32933111000001106: Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Aug 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100378701000001112 Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100378801000001115 Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has dispensed dose form Nebuliser liquid false Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Is a Tobramycin 170mg/1.7ml nebuliser liquid ampoules true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has active ingredient Tobramycin true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has specific active ingredient Tobramycin true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Is a Vantobra true Inferred relationship Existential restriction modifier
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Has manufactured dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) 56 ampoule (8 x 7) x 1.7ml ampoules Has AMP True Vantobra 170mg/1.7ml nebuliser solution 1.7ml ampoules (Pari Medical Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start